PuraPharm (HKG:1498) revised the timetable for its proposed capital reduction and subdivision of unissued shares to Feb. 24, according to a Monday filing with the Hong Kong bourse.
The court hearing for confirmation is scheduled for Jan. 27, in the Cayman Islands. Subject to approval, the changes will take effect on Feb. 24, with trading in the new ordinary shares commencing the same day.
Shareholders can exchange old certificates for new ones from Feb. 24 to March 24.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.